The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Guidelines from the Advisory Committee on Immunization Practices help physicians decide what vaccines to recommend to patients and are also used for determining insurance coverage in the U.S. The ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

Arexvy and Abrysvo are approved to prevent RSV-associated lower respiratory tract disease in adults aged 50 to 59 and 18 to ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

In a report released today, Michael Yee from Jefferies maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...

With petrol cars being banned in five years time is there still room for a £227,570 V6-powered supercar? Express reporter ...

William Stafford Noble, a Naperville native and professor of genome sciences at the University of Washington, urges the ...